Khalid Islam's Insider Trades & SAST Disclosures
Khalid Islam's most recent trade in Fennec Pharmaceuticals Inc was a trade of 25,000 Stock Option done . Disclosure was reported to the exchange on Aug. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Khalid Islam.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 25,000 | 200,000 | - | - | Stock Option | |
| Gain Therapeutics Inc | Khalid Islam | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 09 Aug 2024 | 50,000 | 50,000 | - | 1.0 | 49,940 | Common Stock |
| Gain Therapeutics Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 16 Nov 2023 | 133,333 | 133,333 (0%) | 0% | 2.3 | 307,999 | Common Shares |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 133,333 | 255,492 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 50,000 | 195,492 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 16 Nov 2023 | 50,000 | 193,333 (0%) | 0% | 1.1 | 56,500 | Common Shares |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 20,492 | 175,000 | - | - | Common Shares | |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.44 per share. | 16 Nov 2023 | 20,492 | 213,825 (1%) | 0% | 2.4 | 50,000 | Common Shares |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 16 Nov 2023 | 10,000 | 143,333 (0%) | 0% | 2.7 | 26,900 | Common Shares |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 10,000 | 245,492 | - | - | Common Shares | |
| Gain Therapeutics Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Fennec Pharmaceuticals Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 388,825 | - | - | Stock Option | |
| Gain Therapeutics Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Processa Pharmaceuticals Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 4,392 | 72,486 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 18,208 | 18,208 | - | - | Restricted Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges